Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Calpis, Unilever Form License and Supply Agreement - Nutraceuticals World

What are you searching for?

Sign in
Market Updates

Calpis, Unilever Form License and Supply Agreement

Author Image

By: Sean Moloughney

Editor, Nutraceuticals World

Calpis Co., Ltd., Tokyo, Japan, has entered into an agreement with Unilever, London, U.K., to license the technologies, patents and trademarks, and to provide the blood pressure regulating ingredient AmealPeptide for blood pressure controlling foods to be manufactured and sold by Unilever in Europe. As a result of this licensing agreement, Unilever has launched a blood pressure controlling dairy beverage incorporating AmealPeptide called Becel/Flora pro.activ in Portugal. With the establishment of functional ingredient sales in Europe, Calpis intends to accelerate the expansion of its ingredients and intellectual property business in the U.S. and other areas, and establish the functional ingredients business a one of its mainstay businesses.

Add us as a preferred source on Google

Get the latest Nutraceuticals World news, insights and analysis in your Google Search and AI experiences.

Add Nutraceuticals World as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Nutraceuticals World Newsletters